Case 1:17-cv-00868-CFC-SRF Document 77 Filed 12/27/19 Page 1 of 7 PageID #: 1935
`
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`Plaintiffs,
`
`
`
`v.
`
`
`UNIVERSITY OF MASSACHUSETTS
`and CARMEL LABORATORIES, LLC,
`
`
`
`
`
`L’ORÉAL USA, INC.,
`
`
`
`
`
`
` Case No. 17-cv-868-CFC-SRF
`
`
`
`Defendant.
`
`JOINT CLAIM CONSTRUCTION CHART
`
`
`
`
`Pursuant to Paragraph 15 of the Court’s Scheduling Order (D.I. 46) (as
`
`amended), Plaintiffs University of Massachusetts and Carmel Laboratories, LLC
`
`(together “Plaintiffs”) and Defendant L’Oréal USA,
`
`Inc.
`
`(“Defendant”)
`
`(collectively, the “Parties”) jointly provide this Joint Claim Construction Statement
`
`identifying for the Court the term/phrase of the claims in issue the Parties have
`
`identified for construction, and setting forth each Party’s proposed construction
`
`with citations only to intrinsic evidence.
`
`
`
`The Parties attach a separate text-searchable PDF of each of the patents in
`
`suit. Below is a key for such materials:
`
`
`
`Error! Unknown document property name.
`
`
`
`1
`
`

`

`Case 1:17-cv-00868-CFC-SRF Document 77 Filed 12/27/19 Page 2 of 7 PageID #: 1936
`
`
`
`Exhibit Document Description
`U.S. Patent No. 6,423,327 B1 (Dobson, et al.), dated July 23, 20021
`1.
`2.
`U.S. Patent No. 6,645,513 B2 (Dobson, et. al.), dated November 11, 2003
`
`
`
`I. Disputed Claim Constructions
`
`The following term/phrase is in dispute2:
`
`
`
`
`“wherein the adenosine concentration applied to the dermal cells is”: ’327 Patent,
`claim 1; ’513 Patent, claim 1
`
`
`
`Defendant’s Construction:
`“wherein the adenosine concentration
`applied
`to
`the skin containing
`the
`dermal cells is”
`
`Plaintiffs’ Construction:
`Plain and ordinary meaning.
`
`Alternatively, if construed, “wherein the
`adenosine concentration that reaches the
`dermal cell layer is”
`Intrinsic Evidence:
`
`’327 Patent at 1:19-24; 1:44-67; 2:1-8;
`2:38-40; 2:49-60; 2:67-3:20; 5:10-43;
`6:5-10; 6:15-9:50; Figs 1A, 1B, 2A, 2B,
`Tables 1, 2, 3, 4; Claim 1.
`
`’513 Patent at Claim 1.
`
`File History
`Patent
`’327
`UMASS_00000442 at 553-55; 559.
`
`Plaintiffs reserve the right to rely on any
`
`1 Because the two asserted patents share a nearly identical specification, for the
`Court’s convenience, the Parties cite the specification of the ’327 Patent.
`
`Intrinsic Evidence:
`
`The claims of the ’327 patent,
`including, for example, claims 1, 3,
`5-7, and 9
`
`The claims of the ’513 patent,
`including, for example, claims 1, 3, 5-7,
`and 9
`
`The written description of the ’327
`patent, including, for example,
`Abstract, 1:20-25, 1:35-2:17, 2:30-34,
`
`at
`
` 2
`
` By providing the below proposed construction, L’Oréal USA does not waive
`any claims or defenses of patent invalidity, including under 35 U.S.C. § 112.
`(See, e.g., Defendant’s Initial Invalidity Contentions.) Further, L’Oréal USA
`reserves the right to assert that the language of the claims and their meaning still
`fail to inform, with reasonable certainty, those skilled in the art about the scope
`of the claimed invention. (See, e.g., id.)
`
`Error! Unknown document property name.
`
`2
`
`

`

`Case 1:17-cv-00868-CFC-SRF Document 77 Filed 12/27/19 Page 3 of 7 PageID #: 1937
`
`
`
`intrinsic evidence cited by Defendant.
`
`
`2:38-40, 2:57-60, 4:51-5:39, 6:5-13,
`and 6:15-9:51
`
`The prosecution history of U.S. Pat.
`Appl. No. 09/179,006 (“’006
`application”), including, for example,
`Oct. 26, 1998 Original Application,
`Dec. 22, 1999 Office Action, Mar. 9,
`2000 Response to Dec. 22, 1999 Office
`Action, and May 30, 2000 Final
`Rejection
`
`The prosecution history of U.S. Pat.
`Appl. No. 09/672,348 (“’348
`application”), including, for example,
`Sept. 28, 2000 Original Application
`and Preliminary Amendment, Apr. 20,
`2001 Office Action, July 20, 2001
`Response to Apr. 20, 2001 Office
`Action, Oct. 10, 2001 Office Action,
`Feb. 11, 2002 Response to Oct. 10, 2001
`Office Action, Feb. 13, 2002
`Submission of Signed Declaration, Mar.
`21, 2002 Notice of Allowance, and May
`17, 2002 Comments on Statement of
`Reasons for Allowance
`
`The prosecution history of U.S. Pat.
`Appl. No. 10/184,810 (“’810
`application”), including, for example,
`June 28, 2002 Original Application
`and Preliminary Amendment, Oct. 28,
`2002 Office Action, January 9, 2003
`Response to Oct. 28, 2002 Office
`Action, Apr. 22, 2003 Notice of
`Allowance, and July 7, 2003
`Comments on Statement of Reasons
`for Allowance
`
`The prosecution history of U.S. Pat.
`
`Error! Unknown document property name.
`
`3
`
`

`

`Case 1:17-cv-00868-CFC-SRF Document 77 Filed 12/27/19 Page 4 of 7 PageID #: 1938
`
`
`
`
`
`
`
`
`
`Appl. No. 10/680,370, including, for
`example, Oct. 7, 2003 Original
`Application and Preliminary
`Amendment, Dec. 8, 2004 Office
`Action, June 8, 2005 Response to Dec.
`8, 2004 Office Action, and Sept. 23,
`2005 Office Action
`
`The prosecution history of U.S. Pat.
`Appl. No. 11/473,512, including, for
`example, June 23, 2006 Original
`Application and Preliminary
`Amendment
`
`The prosecution history of U.S. Pat.
`Appl. No. 11/804,904, including, for
`example, May 21, 2007 Original
`Application and Preliminary
`Amendment, July 22, 2008 Office
`Action, Dec. 22, 2008 Response to July
`22, 2008 Office Action, and March 3,
`2009 Office Action
`
`The prior art cited during prosecution
`of the above-referenced applications,
`including, for example, German Patent
`Application DE 195 45 107 A1 and
`Hartzshtark et al., “The Use of
`Indentometry to Study the Effect of
`Agents Known to Increase Skin
`c-AMP Content,” Experientia 41
`(1985): 378, Birkhauser Verlag, CH
`4010 Basel/Switzerland
`
`Any evidence cited by Plaintiffs
`
`Error! Unknown document property name.
`
`4
`
`

`

`Case 1:17-cv-00868-CFC-SRF Document 77 Filed 12/27/19 Page 5 of 7 PageID #: 1939
`
`
`
`Respectfully submitted,
`
`FARNAN LLP
`
`/s/ Brian E. Farnan
`
`
`Brian E. Farnan (Bar No. 4089)
`Michael J. Farnan (Bar No. 5165)
`919 North Market Street, 12th Floor
`Wilmington, DE 19801
`Telephone: (302) 777-0300
`Facsimile: (302) 777-0301
`bfarnan@farnanlaw.com
`mfarnan@farnanlaw,com
`
`
`DATED: December 27, 2019
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Of Counsel:
`William Christopher Carmody
`Tamar E. Lusztig
`Beatrice C. Franklin
`SUSMAN GODFREY L.L.P.
`1301 Avenue of the Americas, 32nd Floor
`New York, NY 10019
`Telephone: (212) 336-8330
`Facsimile: (212) 336-8340
`bcarmody@susmangodfrey.com
`tlusztig@susmangodfrey.com
`bfranklin@susmangodfrey.com
`Justin A. Nelson
`SUSMAN GODFREY L.L.P.
`1000 Louisiana Street, Suite 5100
`Houston, Texas 77002
`Telephone: (713) 651-9366
`Facsimile: (713) 654-6666
`jnelson@susmangodfrey.com
`
`
`Attorneys for University of
`Massachusetts and Carmel
`Laboratories, LLC
`
`
`
`
`Error! Unknown document property name.
`
`5
`
`

`

`Case 1:17-cv-00868-CFC-SRF Document 77 Filed 12/27/19 Page 6 of 7 PageID #: 1940
`
`
`
`
`Matthew B. Lowrie
`FOLEY & LARDNER LLP
`111 Huntington Avenue, Suite 2600
`Boston, MA 02199
`Telephone: (617) 342-4000
`Facsimile: (617) 342-4001
`mlowrie@foley.com
`
`
`
`Attorneys for Carmel Laboratories,
`LLC
`
`
`COMMONWEALTH OF MASSACHUSETTS,
`
`By its attorney,
`
`MAURA HEALEY
`ATTORNEY GENERAL
`
`By: William Christopher Carmody
`William Christopher Carmody
`Special Assistant Attorney General
`SUSMAN GODFREY L.L.P.
`1301 Avenue of the Americas, 32nd Floor
`New York, NY 10019
`Telephone: (212) 336-8330
`Facsimile: (212) 336-8340
`bcarmody@susmangodfrey.com
`
`
`
`
`
`
`
`
`
`Error! Unknown document property name.
`
`6
`
`Attorney for University of
`Massachusetts
`
`/s/ Frederick L. Cottrell, III
`Frederick L. Cottrell, III (#2555)
`Jeffrey L. Moyer (#3309)
`Katharine L. Mowery (#5629)
`RICHARDS, LAYTON & FINGER, P.A.
`One Rodney Square
`
`

`

`Case 1:17-cv-00868-CFC-SRF Document 77 Filed 12/27/19 Page 7 of 7 PageID #: 1941
`
`
`
`920 N. King Street
`Wilmington, Delaware 19801
`(302) 651-7700
`cottrell@rlf.com
`moyer@rlf.com
`mowery@rlf.com
`Attorneys for Defendant
`L’Oréal USA, Inc.
`
`
`OF COUNSEL:
`
`Eric W. Dittmann
`Isaac S. Ashkenazi
`Nicholas A. Tymoczko
`PAUL HASTINGS LLP
`200 Park Avenue
`New York, NY 10166
`
`Dennis S. Ellis
`Katherine F. Murray
`Serli Polatoglu
`PAUL HASTINGS LLP
`515 South Flower Street, 25th Floor
`Los Angeles, CA, 90071
`(213) 683-6000
`
`
`Naveen Modi
`Joseph E. Palys
`PAUL HASTINGS LLP
`875 15th Street, N.W.
`Washington, D.C., 20005
`(202) 551-1990
`
`Error! Unknown document property name.
`
`7
`
`